INTRODUCTION
Long non-coding RNAs (lncRNAs), a new class of non-coding RNAs longer than 200 nucleotides, have been recognized to regulate a wide variety of physiological and pathological processes through diverse mechanisms. Presently, only a small number of lncRNAs have been characterized functionally, and most of them are shown to act as regulators at different levels of gene expression (1, 2). Studies have revealed that many lncRNAs are shown to regulate important cancer hallmarks, including initiation, growth, and metastasis (3). However, whether lncRNA plays a role in cancer related inflammation is not clear yet. Recently, in Cancer Cell, Liu et al. reported a novel lncRNA upregulated by NF-κB (nuclear factor kappaB) was involved in cancer related inflammation by preventing over-activation of NF-κB pathway (4).
Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.